Key facts
- Notable investors include Changxing Fund, Jilin Province Private Equity, Jilin Province Technology Investment Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Tuohua Biology
- ·The full record, as it builds
Funding rounds
No funding rounds for Tuohua Biology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tuohua Biology
Provider of cell biology research and clinical application services based in Siping, China. The company specailises in stem cell products, cell bank storage, SOD based biological products and cell repair peptides, thereby supporting treatment of complex diseases and enhancing development across the broader healthcare ecosystem.
- Sector
- Healthcare
- HQ
- Siping, China
- Founded
- 2010
- Employees
- 64
- Website
- tuohuashengwu.com/
- Ownership
- Privately Held (backing)
Tuohua Biology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tuohua Biology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tuohua Biology in its N-PORT filings yet. We sweep new filings monthly.